Rocket Lab just won the largest launch contract in its history, a $266 million U.S. Space Force award for up to 18 suborbital launches from Kodiak, Alaska. The stock jumped on the news. What makes the contract worth understanding is not its size but what it reveals about a gap between the business investors are pricing and the business Rocket Lab actually runs.
For months, Rocket Lab's stock has moved on one storyline: Neutron, the medium-lift reusable rocket meant to challenge SpaceX, and its repeatedly slipping debut. The shares are down more than 50% from a May peak, largely on anxiety about Neutron delays. This contract has nothing to do with Neutron. It runs on rockets Rocket Lab already flies, and it points at a part of the company the Neutron narrative has been overshadowing.
Two companies wearing one ticker
Rocket Lab is really two businesses, and the market is fixated on the wrong one.
The first is the future business: Neutron, the 13-ton-to-orbit reusable rocket designed to compete with SpaceX's Falcon 9 for satellite launches and national security payloads. It is genuinely important to the long-term story, and it is also not flying yet. Its debut has slipped to the fourth quarter of 2026 after a first-stage propellant tank failed pressure testing in January, and significant work remains, full vehicle integration, static fire tests, regulatory clearance, a launch rehearsal. Every delay hits the stock, because the market has decided Neutron is the thesis.
The second is the business that actually pays the bills right now: launch services on vehicles that already exist and fly. Electron, the company's small orbital rocket, is the most frequently launched small rocket in the world. HASTE, a suborbital variant, provides hypersonic test flights for the U.S. government. This $266 million contract is HASTE work, and it requires no Neutron flight, no new vehicle, nothing that has not already been proven. It draws on infrastructure operating today.
That distinction is the whole point. Investors are discounting the stock on Neutron's timeline while the company keeps booking large, funded contracts on the half of the business that Neutron's drama has nothing to do with.
What "suborbital hypersonic testing" actually is, and why it is a good business
The unglamorous name hides why this is a durable revenue line rather than a one-off.
Hypersonic weapons, which travel above five times the speed of sound, are a top defense priority for the U.S. and its rivals, and developing them requires flight testing, repeatedly launching test vehicles to hypersonic speeds to see how designs, materials, and guidance systems behave. That demand for test launches is large, sustained, and funded by defense budgets rather than by the commercial-space cycle. HASTE, derived from the proven Electron, is built precisely to provide those test flights.
Three features make it attractive. It uses existing, flight-proven hardware, so the execution risk is low compared with a rocket still in development. It serves a government customer with a strategic priority and deep pockets, which means the demand is stable and not dependent on the boom-and-bust of commercial launch. And it faces limited competition, because few companies can offer repeatable, dedicated hypersonic test launches at cadence. This is not the glamorous part of Rocket Lab. It may be the more dependable part.
The Kodiak detail underlines the moat. Rocket Lab is running these launches from the Pacific Spaceport Complex in Alaska, described as the only U.S. commercial spaceport with unobstructed access to polar-orbit range, which is exactly the trajectory profile much hypersonic testing needs. Physical launch sites with the right geography and regulatory clearance are genuinely scarce, and holding one is an asset competitors cannot quickly replicate.
Reading the contract honestly
A few things about the deal deserve a clear eye, because the headline number is doing some work.
The $266 million covers 12 firm launches with options for six more, running toward 2028, and Rocket Lab did not break out how much of the figure is base versus options. So the full value depends on options that may or may not be exercised, and the firm commitment is smaller than the headline. The contract also represents about 12% of the company's $2.2 billion backlog reported earlier this year, which is meaningful but not transformative on its own.
There is also a wrinkle worth noting on the market reaction: elements of this award had been signaled before, so part of Tuesday's pop was the market re-reacting to a firmed-up version of previously known information, which happens often with government contracts announced in stages. The news is real, but the surprise was smaller than the price move suggested.
None of that undercuts the point. Even read conservatively, this is a large, funded contract on the existing-vehicle side of the business, and it lands while the stock is being punished for the developing-vehicle side. That is the mispricing worth seeing.
The procurement wave underneath
The contract is not an isolated win. It sits inside a defense-spending expansion that changes the backdrop for the whole company.
The Space Force recently expanded its National Security Space Launch Phase 3 Lane 1 program from $5.6 billion to $17 billion, adding $11.4 billion and roughly tripling the estimated mission count through fiscal 2029. Rocket Lab is one of seven companies eligible to compete for those task orders, alongside SpaceX, ULA, Blue Origin, and others. The government is buying launch capacity at a scale and pace it has not before, and it is deliberately spreading awards across multiple providers to avoid depending on any single one.
That environment favors an established, flight-proven provider with government relationships, which Rocket Lab is. Here, though, the Neutron distinction returns and cuts the other way: to win the orbital Lane 1 national-security task orders, Rocket Lab needs Neutron to complete a successful first flight. So Neutron still gates the largest future opportunity. What the suborbital contract shows is that Rocket Lab can generate substantial government revenue while it waits, which lowers the risk of the wait without eliminating Neutron's importance.
How to read it
The clean way to hold this is that Rocket Lab has a proven, growing, government-anchored launch-and-test business generating real revenue today, and a separate, higher-stakes bet on Neutron that will determine how large the company can eventually become. The market has been trading almost entirely on the second and heavily discounting the stock on its delays, while the first keeps delivering contracts like this one.
That does not make the stock cheap or the concerns misplaced. Neutron genuinely matters, its delays are a real execution risk, and the largest future contracts do depend on it flying. First-quarter revenue rose more than 60% year over year with backlog up more than 100%, which is strong, and the company is also digesting a roughly $8 billion agreement to acquire the satellite operator Iridium, which is a large, separate bet on vertical integration that carries its own risk. This is not a simple story in either direction.
But the specific insight this contract offers is worth carrying: when a company is valued almost entirely on one anxiously watched milestone, it is easy to miss that another part of the same company is quietly signing its biggest deals ever, on hardware that already works, funded by a customer that is increasing its spending. The suborbital business is the part of Rocket Lab that is working now, and it is the part the Neutron narrative keeps hiding. The stock trades on the rocket that has not flown. The revenue, increasingly, comes from the ones that already have.